The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.675
Bid: 18.35
Ask: 19.00
Change: -0.075 (-0.40%)
Spread: 0.65 (3.542%)
Open: 18.75
High: 0.00
Low: 0.00
Prev. Close: 18.75
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Secondary Listing on the Tel Aviv Stock Exchange

8 Jul 2019 07:00

RNS Number : 7134E
BATM Advanced Communications Ld
08 July 2019
 

LEI: 213800FLQUB9J289RU66

 

8 July 2019

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

Secondary Listing on the Tel Aviv Stock Exchange

BATM (LSE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that, further to its placing to raise $18 million and intention to seek a secondary listing on the Tel Aviv Stock Exchange ("TASE") announced on 24 June, the Group has today applied for the listing of its ordinary shares on TASE and trading is expected to commence on 11 July 2019. Based on its current market capitalisation, BATM expects to become a constituent of the TA-90 index, which is one of TASE's leading indices and tracks the 90 shares with the highest market capitalisation that are not included in the TA-35 index.

 

BATM is pursuing the secondary listing in order to:

· provide a local trading platform for the Israeli-based institutions that have recently become shareholders in the Group;

· expand the accessibility of its shares to a wider pool of investors; and

· increase the breadth and depth of the Group's shareholder base, with the aim of ultimately improving the liquidity and tradability of its shares.

 

The ordinary shares of the Group will continue to trade on the Main List of the London Stock Exchange ("LSE"), where BATM has been listed since 12 July 1999. The shares listed on TASE will be fully transferrable and fungible with those listed on the LSE, the Group's primary listing. BATM is not issuing any new shares in connection with the secondary listing.

 

Dr Zvi Marom, Chief Executive Officer of BATM, said: "This is an exciting time for BATM with great progress being made across our business and listing on TASE will expand the accessibility of our growth story to a wider pool of investors. We are a global company that has its headquarters and extensive operations in Israel and recently raised $18 million from investors in the UK and Israel. As a result, and with the ease of being able to trade between the LSE and TASE platforms, this is a natural step to strengthen our investment profile. By expanding the breadth and depth of our shareholder base, combined with sustained growth, we look forward to increasing the liquidity of our stock and delivering value to all investors."

 

 

Enquiries:

 

BATM Advanced Communications

Dr. Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

Shore Capital Stockbrokers

Mark Percy, Anita Ghanekar

+44 20 7408 4050

Luther Pendragon

Harry Chathli, Claire Norbury, Joe Quinlan

+44 20 7618 9100

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBRGDRGGGBGCR
Date   Source Headline
2nd May 20247:00 amRNSBATM selected for TB diagnostics programme
18th Apr 20247:00 amRNSBATM to deliver Edgility to new Tier 1 customer
8th Apr 20247:00 amRNSBATM awarded new Edgility contract from Cemex
3rd Apr 20247:00 amRNSAnnual Financial Report
26th Mar 20247:00 amRNSBATM receives $2.3m cyber security orders
12th Mar 20247:00 amRNSFull Year Results
29th Feb 20247:00 amRNSNotice of Results
2nd Jan 20247:00 amRNSTotal Voting Rights
30th Nov 20237:03 amRNSBlock Listing Application
27th Nov 20237:00 amRNSBlock Listing Interim Review
30th Oct 20237:00 amRNSBATM receives $3m cyber security order
23rd Oct 20237:00 amRNSADOR Diagnostics secures $7.5m investment
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20237:00 amRNSNew Edgility order for US Emergency Services
9th Oct 20237:00 amRNSResponse to recent developments in Israel
6th Sep 20237:00 amRNSBATM receives $3.4m cyber security contract
29th Aug 20237:00 amRNSInterim Results
13th Jul 202311:30 amRNSResult of AGM and Director Appointment
8th Jun 20237:00 amRNSNotice of Annual General Meeting
6th Jun 20237:00 amRNSCapital Markets Day
5th Jun 20237:00 amRNSNew contract win for Edgility
10th May 20232:30 pmRNSCapital Markets Day and Investor Presentation
17th Apr 20237:00 amRNSEdgility rollout progressing ahead of schedule
4th Apr 20233:30 pmRNSAnnual Financial Report
6th Mar 20237:00 amRNSFull Year Results
24th Feb 20237:00 amRNSNotice of Results
1st Feb 20237:00 amRNSAppointment of Chief Financial Officer
9th Jan 20237:00 amRNSBATM receives $26m cyber security order
3rd Jan 20233:30 pmRNSGrant of Options
21st Dec 202212:00 pmRNSResult of AGM
21st Dec 20227:00 amRNSTransaction in Own Shares and TVR
20th Dec 20227:00 amRNSTransaction in Own Shares and TVR
19th Dec 20227:00 amRNSTransaction in Own Shares and TVR
16th Dec 20227:00 amRNSTransaction in Own Shares and TVR
15th Dec 20227:00 amRNSTransaction in Own Shares and TVR
14th Dec 20227:00 amRNSTransaction in Own Shares and TVR
13th Dec 20227:00 amRNSTransaction in Own Shares and TVR
9th Dec 20227:00 amRNSTransaction in Own Shares and TVR
8th Dec 20227:00 amRNSTrading Update
25th Nov 20221:00 pmRNSBlock Listing Interim Review
24th Nov 20224:00 pmRNSNotice of Annual General Meeting
27th Oct 20227:00 amRNSADOR and BIOASTER to develop STI diagnostic tests
18th Oct 20227:00 amRNSMulti-year contract with CityFibre for Edgility
6th Oct 20227:00 amRNSDirectorate Changes
24th Aug 20227:00 amRNSInterim Results
19th Jul 20227:00 amRNSAppointment of CEO of ADOR Diagnostics
11th Jul 20227:00 amRNSBATM partners with CityFibre for Edgility
16th Jun 20224:36 pmRNSPrice Monitoring Extension
26th May 20227:00 amRNSBlock Listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.